Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02133183
What this trial is testing

Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03743662
What this trial is testing

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)UnknownNCT00014105
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Atlantic Health System
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT03973879
What this trial is testing

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Darell Bigner
Testing effectiveness (Phase 2)Study completedNCT01290263
What this trial is testing

Amgen 386 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Dana-Farber Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT00481455
What this trial is testing

Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Recurrent Glioblastoma Multiforme
CASI pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06177964
What this trial is testing

Lerapolturev (PVSRIPO) in GBM

Who this might be right for
Recurrent Supratentorial Glioblastoma
Darell Bigner 92
Testing effectiveness (Phase 2)Study completedNCT01856933
What this trial is testing

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Who this might be right for
GBMGlioblastoma MultiformeGliosarcoma
Heinrich Elinzano, MD 6
Testing effectiveness (Phase 2)Study completedNCT00003301
What this trial is testing

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT05465954
What this trial is testing

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Who this might be right for
High Grade Astrocytic TumorRecurrent Glioblastoma, IDH-WildtypeRecurrent Gliosarcoma
Mayo Clinic 54
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Large-scale testing (Phase 3)Study completedNCT00118222
What this trial is testing

High Light and Low Light Dose PDT in Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Case Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT00003463
What this trial is testing

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Not applicableUnknownNCT05811793
What this trial is testing

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Who this might be right for
Glioblastoma
Second Affiliated Hospital of Nanchang University 36
Testing effectiveness (Phase 2)WithdrawnNCT04118036
What this trial is testing

Abemaciclib + Pembrolizumab In Glioblastoma

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute
Early research (Phase 1)Looking for participantsNCT06186401
What this trial is testing

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Who this might be right for
EGFR Gene MutationGlioblastomaMGMT-Unmethylated Glioblastoma+1 more
Hideho Okada, MD, PhD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06061809
What this trial is testing

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
ImmunityBio, Inc. 34
Testing effectiveness (Phase 2)Looking for participantsNCT06011109
What this trial is testing

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Who this might be right for
GliomaGlioblastoma Multiforme
Aveta Biomics, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT04469699
What this trial is testing

Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme, Adult
University Hospital Muenster 30
Next Page